HIF1A and ovarian cancer: It is possible that TRPM7 silencing may activate the AMPK to promote HIF-1α ubiquitination proteasomal degradation that attenuates the HIF-1α-enhanced glycolysis to shift glycolysis to OXPHOS, inhibiting the proliferation of ovarian cancer cells (Fig. 8).